GCG and Hepatic fibrosis: Regarding drug-induced effects on liver fibrosis, Dr. Judith Ertle presented the positive outcomes of a GLP-1/glucagon dual agonist, survodutide, which acts mainly through a weight-dependent mechanism of action.